Pemphigus Market Research Report – Forecast to 2030

Pemphigus Market Research Report: By Type (Pemphigus Vulgaris and Others), by Diagnosis (Skin Peeling, Endoscopy, and Others), by Treatment (Corticosteroid, Biological Therapies, and Others), by End-Users (Hospitals and Others)– Forecast Till 2030

ID: MRFR/Pharma/5024-HCR | | Region: Global | 100 Pages         

Pemphigus Market Speak to Analyst Request a Free Sample

Pemphigus Market Overview


According to the latest research report, the global pemphigus market size is predicted to increase at a high rate over the projected period. According to market research analysts, the pemphigus market is predicted to grow at a compound annual growth rate of a CAGR of 6.4%  during the projected timeframe from 2020 to 2030. Pemphigus is an inflammatory illness that affects the immune system. It is a collection of uncommon skin conditions that produce blisters and ulcers in the mouth, skin, and genitals, among other symptoms. In pemphigus, the immunological system creates antibodies that are wrongly directed against healthy tissue in the skin and mucosa. It may arise as a secondary effect of medicine after eating certain blood pressure medications.


The rising incidence of cancer, increased tobacco usage, addictive personality, increased pollution, growing elderly population, and increased knowledge about oral hygiene are all expected to contribute to the development of this market in the coming years. Pelagius condition affects around 2,500 persons in the United States, according to the International Pemphigus and Pemphigoid Foundation (IPPF). In addition, it was discovered that there were 40,000 to 50,000 cases of pemphigus in the globe in the year 2017.


This report contains all the information on the global pemphigus market analysis and its strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other essential factors. And a detailed analysis of the pemphigus market forecast for 2027 is also included in the report.


Covid 19 Analysis


COVID19 had a significant impact on a wide range of industries, including restrictions on shipping and logistics, as well as foreign bans. In addition, the outbreak created a situation where both commercial and industrial enterprises were shut down for an abnormally long period of time. This resulted in financial instability and has affected the pemphigus market value as well. 


Market Dynamic


Drivers


Pemphigus market growth is being driven by a rise in the number of instances of uncommon autoimmune illnesses, as well as higher consumption of blood pressure drugs, chelating compounds, and pyrazolones. Pemphigus market growth is further boosted by greater exposure to UV radiation, psychological anguish, and thermal burns, all of which contribute to the disease's spread.


Opportunities


In addition to advancements in the management of autoimmune illnesses, an increasing number of people suffering from autoimmune system illnesses, including myasthenia gravis and thymoma, throughout the globe will propel the worldwide pemphigus market forward.


Restraints


Although several factors are driving the market, considerations such as rapidly increasing health expenditures, an increase in the total count of research and innovation, an unfavourable cost recovery environment, and strict regulations policies may limit the market's growth during the period of assessment.


Challenges


During the time under consideration, an unfavourable cost recovery environment, as well as rigorous regulatory rules, may create challenges for the market's expansion.


Cumulative Growth Analysis


In terms of market share, Europe is trailing behind the United States. It is predicted that the existence of nations such as France, the United Kingdom, Germany, and others would help to propel the growth in the region ahead. The increasing number of persons of Mediterranean heritage in these two locations is causing a substantial growth in the percentage of people afflicted by the illness within those two areas.


The Americas has the capacity to rise at a compound annual growth rate (CAGR) of X per cent over the course of the evaluation period, reaching a market capitalization of USD XX million over the course of the year 2027. By 2027, the European pemphigus demand is anticipated to have reached a value of USD XX million.


Value Chain Analysis


According to the reports, In order to better understand the worldwide pemphigus market, it has been divided into five categories: kinds, diagnosis, therapy, end-users, and regions. On the basis of the kinds of pemphigus, the market is further subdivided into the following categories: paraneoplastic pemphigus. Pemphigus foliaceus, pemphigus vulgaris, and pemphigus vegetans. In terms of diagnosis, the industry has been divided into the following categories: skin biopsy, skin peeling, blood testing, and endoscopy.


The market has been categorized according to treatment into corticosteroids, initial therapy, and maintenance therapy. Immunosuppressive drugs, biological treatments, intravenous immunoglobulin (IVIG) therapy, and other medications are used to treat the condition. The end-user market is divided into four categories: academic and research organizations, hospitals and clinics, labs, and others.


The pemphigus market has been classified into four regions: the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The pemphigus market in the Americas has been further classified into North America and South America, with the US and Canada constituting the North American market. Western Europe and Eastern Europe comprise the European pemphigus market. Western Europe is further subdivided into the United Kingdom, Germany, Italy, France, Spain, and the rest of Western Europe.


The Asia-Pacific pemphigus market has been classified as follows: India, Japan, China, Australia, South Korea, and the rest of Asia-Pacific. The Middle East & Africa pemphigus market has been split into the Middle East and Africa.


Segmentation Overview


The market is segmented based on the kinds, diagnosis, therapy, end-users, and regions. The global pemphigus market trends is expected to witness decent growth during the forecast period.


By Application


The Application is segmented into corticosteroids, initial therapy, and maintenance therapy. Immunosuppressive drugs, biological treatments, intravenous immunoglobulin (IVIG) therapy, and other medications.


By end-users


The market is segmented into academic and research organizations, hospitals and clinics, labs, and others based on the propulsion types.


Regional Analysis


According to the reports, the pemphigus market has been broken down into the Americas, Europe, Asia-Pacific, and the Middle East & Africa regions by geography. Due to the rising number of older populations, increased government spending on dental hygiene, the availability of disposable money and the rising use of tobacco in Europe, Europe is predicted to be the 2nd biggest pemphigus market share in the world. In the year 2017, occurrences of pemphigus documented by the Europe PMC ranged from 0.5 instances per million inhabitants in Germany to 8 occurrences per million population in Greece, with a total of 1.6,16.1.


Pemphigus and other dental health issues are developing in emerging nations, where people have more disposable money and can afford to spend more on healthcare coverage. Emerging economies in the Middle East and Africa are predicted to have the smallest share of the worldwide pemphigus market outlook due to lack of expansion, lack of technological understanding, and insufficient healthcare centres.


Competitive landscape


Several participants in the worldwide pemphigus market have shown a strong interest in advancing their prospects by strategically improving their competitive position.


Major Key Players



  • Novartis Pharmaceuticals

  • Hoffmann-La Roche

  • Principia Biopharma, Inc

  • Argenx

  • Sanofi S.A

  • Pfizer Inc

  • Teligent Inc

  • GlaxoSmithKline LLC

  • Teva Pharmaceutical Industries.


Report Overview


The following report comprises of –



  • Market overview 

  • Covid 19 Analysis

  • Market Dynamic

  • Drivers

  • Opportunities

  • Restraints 

  • Challenges

  • Cumulative Growth Analysis

  • Value Chain Analysis

  • Segmentation Overview 

  • By Application 

  • By End-Users

  • Regional Analysis

  • Competitive landscape


Recent Developments



  • As a result of technology developments, higher research expenditures, and improvements in healthcare system in emerging nations across the Asia-Pacific region, the market is expected to grow at a rapid rate in the coming years.


Global Pemphigus Market, by Pemphigus Types



  • Pemphigus Vulgaris

  • Pemphigus Foliaceus

  • Pemphigus Vegetans

  • Paraneoplastic Pemphigus


Global Pemphigus Market, by Diagnosis



  • Skin peeling

  • Skin biopsy

  • Run blood tests

  • Endoscopy


Global Pemphigus Market, by Treatment



  • Initial therapy

  • Maintenance therapy

  • Immunosuppressants

  • Biological therapies

  • Intravenous Immunoglobulin (IVIG) therapy

  • Other medication


Global Pemphigus Market, by End User



  • Laboratories

  • Hospitals and Clinics

  • Academic and Research Institutes


Global Pemphigus Market, by Region



  • Americas



  • North America

  • US

  • Canada

  • South America



  • Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe



  • Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • Republic of Korea

  • Rest of Asia Pacific



  • Middle East & Africa

  • Middle East

  • Africa



Report Scope:

Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2020-2030:~ 6.4%
  Base Year   2019
  Forecast Period   2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Diagnosis, Treatment, And End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Novartis Pharmaceuticals, Hoffmann-La Roche, Principia Biopharma, Inc, Argenx, Sanofi S.A., Pfizer Inc., Teligent Inc, GlaxoSmithKline LLC, Teva Pharmaceutical Industries.
  Key Market Opportunities

  • Healthcare expenditure
  • Research and development
  •   Key Market Drivers

  • Increasing prevalence of cancer, consumption of tobacco, unhealthy lifestyle
  • Increasing geriatric population and increasing awareness for oral hygiene


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Pemphigus is a group of rare autoimmune skin disorders that cause blisters, sores on the skin, in the mouth, or on the genitals.

    The market is expected to exhibit a strong 6.4% CAGR over the forecast period from 2020-2030.

    The increasing prevalence of cancer is likely to be a major driver for the Pemphigus Market over the forecast period.

    Americas are anticipated to dominate the global Pemphigus Market.

    Leading players in the market include Novartis, Principia Biopharma, and Pfizer, among others.